Key Points AngioDynamics beat earnings this morning. The company did that not by earning more than expected, though, but by losing less than expected. Full-year earnings will still be negative. 10 stocks we like better than AngioDynamics › AngioDynamics (NASDAQ: ANGO) stock soared 10.5% through 11:25 a.m. ET Thursday after beating on "earnings" (sort of) this morning. Heading into the report, analysts forecast AngioDynamics would lose $0.12 per share in its fiscal Q1 2026, on sales of$72.7 milli ...